Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6A14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,140
Award facts
- Contract value 100% obligated
- $35,140.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,140.33 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, issued on January 27, 2026, with an ultimate completion date of January 28, 2026, was awarded on a non-competitive, firm fixed-price basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
The delivery order for Repatha, a specialty cardiovascular medication used for cholesterol management, reflects the ongoing pharmaceutical supply needs of the Defense Health Agency and other federal military healthcare systems. As a critical component of the military medical supply chain, this order demonstrates AmerisourceBergen's continued role as a primary vendor for brand-name pharmaceutical products supporting Department of Defense healthcare operations. The non-set-aside designation indicates this award was competitively procured through the existing indefinite delivery contract vehicle, consistent with AmerisourceBergen's extensive portfolio of federal pharmaceutical deliveries across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F6A14?
SPE2DR26F6A14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F6A14 worth?
The government has obligated $35,140 on SPE2DR26F6A14.
Is contract SPE2DR26F6A14 an order under another contract?
Yes. SPE2DR26F6A14 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F6A14 competed?
The extent of competition for SPE2DR26F6A14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award